Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Digoxin, the most widely used cardiac glycoside, undergoes significant metabolic conversion in many patients to cardioinactive metabolites in which the lactone ring is reduced. This appears to occur within the gastrointestinal tract. An attempt was made to isolate and identify the organisms capable of reducing digoxin from stool cultures obtained from human volunteers. Of hundreds of isolates studied, only Eubacterium lentum , a common anaerobe of the human colonic flora, converted digoxin to reduced derivatives. Such organisms were also isolated in high concentrations from the stools of individuals who did not excrete these metabolites when given digoxin in vivo. When the growth of E. lentum was stimulated by arginine, inactivation of digoxin was inhibited. Neither the presence of these organisms alone nor their concentration within the gut flora appeared to determine whether digoxin would be inactivated by this pathway in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“neither the presence nor the abundance of this species predicts digoxin reductions64–66. This discrepancy appears to be driven by strain-level variations in the E. lenta population67.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [64]
Citations
Cites
Human Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians
Moore, W. E. C., & Holdeman, L. V. (1974) · Applied Microbiology · doi:10.1128/am.27.5.961-979.1974 · Cited by 1,144
Effect of diet on human fecal flora: comparison of Japanese and American diets
Finegold, S. M., Attebery, H. R., & Sutter, V. L. (1974) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.12.1456 · Cited by 518
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423
Self-citationFecal microbial flora in Seventh Day Adventist populations and control subjects
Finegold, S., Sutter, V., Sugihara, P., Elder, H., Lehmann, S., & Phillips, R. (1977) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/30.11.1781 · Cited by 187
Fecal bacteriology of colonic polyp patients and control patients.
Finegold, S. M., Flora, D. J., Attebery, H. R., & Sutter, V. L. (1975) · PubMed · Cited by 137
Digoxin Metabolism in Patients
Peters, U. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630320018009 · Cited by 84
Unusually large digitalis requirements
Luchi, R. J., & Gruber, J. W. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90049-1 · Cited by 78
Urinary excretion of reduced metabolites of digoxin
Lindenbaum, J., Tse-Eng, D., Butler, V. P., & Rund, D. G. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90260-6 · Cited by 73
Self-citationDIHYDRODIGOXIN: A COMMON METABOLITE OF DIGOXIN IN MAN
CLARK, D. R., & Kalman, S. M. (1974) · Drug Metabolism and Disposition · doi:10.1016/s0022-5347(24)07322-1 · Cited by 65
Arginine, a growth-limiting factor for Eubacterium lentum
Sperry, J. F., & Wilkins, T. D. (1976) · Journal of Bacteriology · doi:10.1128/jb.127.2.780-784.1976 · Cited by 61
Research works printed but not linked: 4
- Clark, D. R., Drug Metab. Dispos. 2: 148 (1974).
- Portius, H. J., Arzneim.-Forsch. (Drug Res.) 14: 1073 (1964).
- Butler, V. P., J. Pharmacol. Exp. Ther. 221: 123 (1982).
- Finegold, S. M., Cancer Res. 35: 3407 (1975).
Cited by
Items 101–200 of 287
Ha, Y. W., Na, Y., Ha, I. J., Kim, D., & Kim, Y. S. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.08.002 · Cited by 42
Mousa, S., Sarfraz, M., & Mousa, W. K. (2023) · Metabolites · doi:10.3390/metabo13050674 · Cited by 41
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability
Flowers, S. A., Bhat, S., & Lee, J. C. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2428 · Cited by 42
The pharmaco-toxicological conundrum of oleander: Potential role of gut microbiome
Dey, P. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110422 · Cited by 41
Estimating alcohol content of drinks: common errors in applying the unit system.
Stockwell, T. R., & Stirling, L. (1989) · BMJ · doi:10.1136/bmj.298.6673.571-a · Cited by 41
Priputnevich, T. V., Lyubasovskaya, L. A., Muravieva, V. V., Kondrakhin, A. P., Игнатьева, А. Е., Gordeev, A. B., Shmakov, R. G., Sukhikh, G. T., & Львовна, Я. Е. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1602602 · Cited by 40
Deglycosylated Products of Endogenous Digoxin-like Immunoreactive Factor in Mammalian Tissue
Qazzaz, H. M. A. M., Goudy, S. L., & Valdes, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8731 · Cited by 40
Impacts of gut microbiota alteration on age-related chronic liver diseases
Adhikary, S., Esmeeta, A., Dey, A., Banerjee, A., Saha, B., Gopan, P., Duttaroy, A. K., & Pathak, S. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.017 · Cited by 38
Orally Administered Drugs and Their Complicated Relationship with Our Gastrointestinal Tract
Bashiardes, S., & Christodoulou, C. (2024) · Microorganisms · doi:10.3390/microorganisms12020242 · Cited by 38
Clinical use of serum digoxin concentrations
Lewis, R. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91258-6 · Cited by 37
Digoxin Toxicity Secondary to Clarithromycin Therapy
Nawarskas, J. J., McCarthy, D. M., & Spinler, S. A. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100711 · Cited by 37
Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer’s Disease
Kaur, H., Nookala, S., Singh, S., Mukundan, S., Nagamoto-Combs, K., & Combs, C. K. (2021) · Cells · doi:10.3390/cells10092370 · Cited by 37
Mirror, mirror on the wall: which microbiomes will help heal them all?
Nayak, R. R., & Turnbaugh, P. J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0622-6 · Cited by 36
Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response
Trepka, K. R., Olson, C. A., Upadhyay, V., Zhang, C., & Turnbaugh, P. J. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022724-100847 · Cited by 36
Malayandi, R., Kondamudi, P. K., Ruby, P. K., & Aggarwal, D. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0185-4 · Cited by 36
Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis
Sayers, E., MacGregor, A. J., & Carding, S. R. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.4.642 · Cited by 36
Erythromycin-Induced Digoxin Toxicity
Morton, M. R., & Cooper, J. W. (1989) · DICP · doi:10.1177/106002808902300908 · Cited by 36
Identification of medication–microbiome interactions that affect gut infection
Kumar, A., Sun, R., Habib, B., Deng, T., Bencivenga-Barry, N. A., Palm, N. W., Ivanov, I. I., Tamblyn, R. M., & Goodman, A. L. (2025) · Nature · doi:10.1038/s41586-025-09273-8 · Cited by 34
Gut microbiome metagenomics to understand how xenobiotics impact human health
Mesnage, R., Antoniou, M. N., Tsoukalas, D., Goulielmos, G. N., & Tsatsakis, A. M. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.02.002 · Cited by 34
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities
Martinelli, F., & Thiele, I. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387400 · Cited by 33
Shen, H., Tong, X., Yang, J., Yu, L., Zhou, H., Wang, Y., He, Y. T., Wan, H., & Li, C. (2020) · Food & Function · doi:10.1039/d0fo00775g · Cited by 33
A prospective study of the clarithromycin-digoxin interaction in elderly patients
Zapater, P., Reus, S., Tello, A., Torrús, D., Pérez-Mateo, M., & Horga, J. F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf176 · Cited by 32
The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure
Cienkowski, K., Cienkowska, A., Kupczyńska, K., & Bielecka-Dabrowa, A. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040894 · Cited by 31
Interethnic variation in the metabolic inactivation of digoxin by the gut flora
Alam, A. N., Saha, J. R., Dobkin, J. F., & Lindenbaum, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90299-5 · Cited by 30
Self-citationPadhye, T., Maravajjala, K. S., Swetha, K. L., Sharma, S., & Roy, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102178 · Cited by 29
The microbiota revolution: Excitement and caution
Rescigno, M. (2017) · European Journal of Immunology · doi:10.1002/eji.201646576 · Cited by 29
Qazzaz, H. M. A. M., El-Masri, M. A., & Valdes, R. (2000) · Endocrinology · doi:10.1210/endo.141.9.7664 · Cited by 29
Bokkenheuser, V. D. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.supplement_4.s427 · Cited by 28
Clarithromycin-Induced Digoxin Intoxication
Laberge, P., & Martineau, P. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100908 · Cited by 27
Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome
Mallory, E. K., Acharya, A., Rensi, S., Turnbaugh, P. J., Bright, R. A., & Altman, R. B. (2017) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813235533_0006 · Cited by 26
Dietary Fibers: A Way to a Healthy Microbiome
Sharma, P., Bhandari, C., Kumar, S., Sharma, B., Bhadwal, P., & Agnihotri, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811440-7.00011-9 · Cited by 26
The new microbiology: cultivating the future of microbiome-directed medicine
Ha, C. W. Y., & Devkota, S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00093.2020 · Cited by 25
Braccia, D. J., Ndjite, G. M., Weiss, A., Levy, S., Abeysinghe, S., Jiang, X., Pop, M., & Hall, B. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000898 · Cited by 24
Methodological Considerations for the Study of Bacterial Metabolism
Coates, M. E., Drašar, B. S., Mallett, A. K., & Rowland, I. R. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-599920-5.50005-4 · Cited by 24
Microbiome First Medicine in Health and Safety
Dietert, R. R. (2021) · Biomedicines · doi:10.3390/biomedicines9091099 · Cited by 23
Review and Comparison of Advanced‐Generation Macrolides Clarithromycin and Dirithromycin
McConnell, S. A., & Amsden, G. W. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.6.404.31054 · Cited by 23
Two Cases of Clarithromycin‐Induced Digoxin Toxicity
Guerriero, S. E., Ehrenpreis, E. D., & Gallagher, K. L. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03796.x · Cited by 22
Qazzaz, H. M. A. M., Jortani, S. A., Poole, J. M., & Valdes, R. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.7.1092 · Cited by 22
Reduction of 17-keto steroids by anaerobic microorganisms isolated from human fecal flora
Winter, J., Locascio, S., Bokkenheuser, V. D., Mosbach, E. H., & Cohen, B. I. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90067-5 · Cited by 22
Chamberlain, D. A. (1985) · Heart · doi:10.1136/hrt.54.3.227 · Cited by 22
Connecting the dots: Targeting the microbiome in drug toxicity
Luo, Y., & Zhou, T. (2021) · Medicinal Research Reviews · doi:10.1002/med.21805 · Cited by 21
A toxic shrub turned therapeutic: The dichotomy of Nerium oleander bioactivities
Sharma, R. K., Singh, S., Tewari, N., & Dey, P. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107047 · Cited by 21
Possible Drug Interaction Between Digoxin and Azithromycin in a Young Child
Eick, A. P. T., Sallee, D., Preminger, T. J., Weiss, A., & Reed, M. D. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200020010-00008 · Cited by 21
Cardiac Glycosides Drug Interactions of Clinical Significance
Magnani, B., & Malini, P. L. (1995) · Drug Safety · doi:10.2165/00002018-199512020-00003 · Cited by 21
Shen, Y., Yu, Y., Wei, L., Li, S., Xu, Z., Jin, J., Xia, Y., Xing, H., Chen, X., Xiong, A., et al. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2525-z · Cited by 20
Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors
Kyaw, T. S., Zhang, C., Sandy, M., Trepka, K. R., Zhang, S., Hernandez, L. A. R., Ramirez, L., Goh, J. J., Yu, K., DiMassa, V., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110122 · Cited by 18
Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomics
Ebadpour, N., Abavisani, M., & Sahebkar, A. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2509283 · Cited by 18
Recent Progress in Engineering Human-Associated Microbiomes
Yaung, S. J., Church, G. M., & Wang, H. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0554-6_1 · Cited by 19
A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota
Gulnaz, A., Chang, J., Maeng, H., Shin, K., Lee, K., & Chae, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00600-z · Cited by 18
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00377-2 · Cited by 17
Tutorial: Microbiome studies in drug metabolism
Dodd, D., & Cann, I. (2022) · Clinical and Translational Science · doi:10.1111/cts.13416 · Cited by 17
PARASKEVAIDIS, I. A., Briasoulis, Α., & Tsougos, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031716 · Cited by 17
Clinical Microbiome Analysis by Mass Spectrometry–Based Metaproteomics
Zhang, X., Ning, Z., Mayne, J., & Figeys, D. (2025) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071124-113819 · Cited by 17
Gut microbiota: what is its place in pharmacology?
Tarasiuk, A., & Fichna, J. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1670058 · Cited by 17
Ervin, S. M., & Redinbo, M. R. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0155 · Cited by 17
Buttimer, C., Bottacini, F., Shkoporov, A. N., Draper, L. A., Ross, R. P., & Hill, C. (2022) · Microorganisms · doi:10.3390/microorganisms10010195 · Cited by 17
Berard, A. R., Perner, M., Mutch, S. A., Zuend, C. F., McQueen, P., & Burgener, A. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12977 · Cited by 17
Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
Curini, L., & Amedei, A. (2021) · Biomedicines · doi:10.3390/biomedicines9101338 · Cited by 17
Absence of an Interaction Between Tigecycline and Digoxin in Healthy Men
Zimmerman, J. J., Harper, D. M., Matschke, K. T., Speth, J., Raible, D. G., & Fruncillo, R. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.6.835 · Cited by 17
Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?
Lu, L., Wu, Y., Zuo, L., Luο, X., & Large, P. J. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1507-x · Cited by 16
Shomo, R. E., Chandrasekaran, A., Marshall, A. G., Reuning, R. H., & Robertson, L. W. (1988) · Journal of Mass Spectrometry · doi:10.1002/bms.1200150510 · Cited by 16
Interaction of drugs with gut microbiota modulators
Kim, D. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2197178 · Cited by 15
Investigations of Hydrazine Cleavage of Eltrombopag in Humans
Deng, Y., Rogers, M., Sychterz, C. J., Talley, K., Qian, Y., Bershas, D. A., Ho, M. Y. K., Shi, W., Chen, E. P., Serabjit‐Singh, C. J., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040188 · Cited by 15
Markey, S. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385471-1.00011-8 · Cited by 15
Clarithromycin induced digoxin toxicity.
Nordt, S. P., Williams, S. R., Manoguerra, A. S., & Clark, R. F. (1998) · Emergency Medicine Journal · doi:10.1136/emj.15.3.194 · Cited by 15
Bioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology
Shin, Y. C., Than, N., Park, S. J., & Kim, H. J. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2365254 · Cited by 14
Jain, H., Marsool, M. D. M., Goyal, A., Sulaiman, S. A., Fatima, L., Idrees, M., Sharma, B., Borra, V., Gupta, P., Nadeem, A., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102179 · Cited by 14
Zhang, J., Zhang, J., Wang, R., & Jia, Z. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666181019145159 · Cited by 14
Kidd, J. M., Asempa, T. E., & Abdelraouf, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00013-1 · Cited by 14
Principles and Terminology for Host–Microbiome–Drug Interactions
Heirali, A., Moossavi, S., Arrieta, M., & Coburn, B. A. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad195 · Cited by 13
Drug absorption and bioavailability
Atkinson, A. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819869-8.00027-6 · Cited by 12
Mehmood, K., Moin, A., Hussain, T., Rizvi, S. M. D., Gowda, D., Shakil, S., & Kamal, M. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00926-5 · Cited by 12
Drug Absorption and Bioavailability
Atkinson, A. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369417-1/50044-4 · Cited by 12
Reductive inactivation of digitoxin by Eubacterium lentum cultures
Chandrasekaran, A., Robertson, L. W., & Reuning, R. H. (1987) · Applied and Environmental Microbiology · doi:10.1128/aem.53.4.901-904.1987 · Cited by 12
Ganamurali, N., & Sabarathinam, S. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106792 · Cited by 11
Omics Approaches To Probe Microbiota and Drug Metabolism Interactions
Nichols, R. G., Hume, N. E., Smith, P. B. W., Peters, J. M., & Patterson, A. D. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00236 · Cited by 12
Markey, S. P. (2007) · Elsevier eBooks · doi:10.1016/b978-012369417-1/50051-1 · Cited by 11
Glass, T. L., & Burley, C. Z. (1985) · Applied and Environmental Microbiology · doi:10.1128/aem.49.5.1146-1153.1985 · Cited by 11
New Personalized Medicine Model for Medication Management
Alagiakrishnan, K., Halverson, T., Olivares, D. V. F., & Sadowski, C. A. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16040182 · Cited by 10
Correlation between postmortem microbial signatures and substance abuse disorders
Javan, G. T., Wells, T., Allen, J., Visoná, S. D., Moretti, M., Tipton, C. D., Scott, L., & Finley, S. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274401 · Cited by 11
Couvillion, S., Agrawal, N., Colby, S., Brandvold, K. R., & Metz, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00388 · Cited by 10
Microbiota intestinal: sus repercusiones clínicas en el cuerpo humano
Gigliotti, N. (2013) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2013.523 · Cited by 10
The Modulation of Drug Efficacy and Toxicity by the Gut Microbiome
Wilson, I. D., & Nicholson, J. K. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_15 · Cited by 10
Drug Response Diversity: A Hidden Bacterium?
Hannachi, N., & Camoin‐Jau, L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050345 · Cited by 9
Exploring the influence of the microbiome on the pharmacology of anti-asthmatic drugs
Chan, M., Ghadieh, C., Irfan, I., Khair, E., Padilla, N., Rebeiro, S., Sidgreaves, A., Patravale, V. B., Disouza, J., Cutler, R. L., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02681-5 · Cited by 8
Drug Absorption and Bioavailability
Atkinson, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385471-1.00004-0 · Cited by 8
Gnatzy, L., Ismailos, G., Vertzoni, M., & Reppas, C. I. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106510 · Cited by 8
Bennett, R. G., Beamer, B. A., Greenough, W. B., Lindenbaum, J., & Bartlett, J. G. (1992) · PubMed · Cited by 8
Self-citationChromatography of cardiac glycosides
Vetticaden, S. J., & Chandrasekaran, A. (1990) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82285-9 · Cited by 8
Thalhammer, F., Hollenstein, U., Locker, G. J., Janata, K., Sunder–Plassmann, G., Frass, M., & Burgmann, H. (1998) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1998.00650.x · Cited by 8
Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin
Magnusson, J. O., Bergdahl, B., Bogentoft, C. B., Gustafsson, S., & Jonsson, U. E. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544045 · Cited by 7
The promising path of Oral MOFs: Redefining strategies for gastrointestinal detoxification
Quan, Y., Wu, Y., Wang, K., Ren, H., Zhang, G., Zhao, Y., & Miao, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217168 · Cited by 6
Rithi, A. T., Banerjee, A., Mitra, A., Nethaji, K., Ilanchoorian, D., & Radhakrishnan, A. (2024) · Groundwater for Sustainable Development · doi:10.1016/j.gsd.2024.101187 · Cited by 6
Sebaiy, M. M., & Colyer, C. L. (2017) · Analytical Letters · doi:10.1080/00032719.2017.1312426 · Cited by 6
A systematic review of the relationship between gut microbiota and prevalence of pancreatic diseases
Jankowski, W. M., Fichna, J., & Tarasiuk, A. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107214 · Cited by 5
Causative Role of Anoxic Environment in Bacterial Regulation of Human Intestinal Function
Wang, C., Cancino, A., Baste, J., Marten, D., Joshi, A. A., Nasreen, A., & Bhushan, A. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00735-x · Cited by 5
Do the penicillin antibiotics interact with digoxin?
Rhodes, K. M., & Brown, S. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00191916 · Cited by 5
The meddling microbes midst our medicines
Viswanathan, V. K. (2013) · Gut Microbes · doi:10.4161/gmic.26250 · Cited by 5
Liem, J., Chen, X., Lim, J. J., Mao, Q., Cui, J. Y., & Lin, Y. S. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100284 · Cited by 4
Recent advances and clinical relevance of microbiome dynamics in health and disease
Gavanji, S., Suhail, M., Bencúrová, E., Dandekar, T., & Othman, E. M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2679197 · Cited by 4
Metadata
- Authors
- Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J.
- Affiliations
- Harlem Hospital Center (US)
- Columbia University (US)
- ORCID
- Saha, Jnan R.
- Venue
- Science
- Published
- 1983-04-15
- Volume
- 220
- Issue
- 4594
- Pages
- 325-327
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2083212229
- Cited by
- 259
- References
- 15
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 17 · 2023: 16 · 2022: 10 · 2021: 14 · 2020: 29 · 2019: 12 · 2018: 17 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 8 · 2013: 7 · 2012: 5
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- digoxin, bacterial metabolism, Eubacterium lentum, cardiac glycosides, L-arginine, stool culture
- MeSH terms
- Arginine, Colon, Digoxin, Eubacterium, Feces, Humans, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.